Achieving good blood pressure (BP) control and sustaining effective antihypertensive treatment remain a major challenge for those involved in the long-term management of hypertension. In the current issue, Morawski et al1 report the results of a study using a mobile health (mHealth) tool, called Medisafe, a highly rated smartphone app for medication management, which allows patients to track medication intake and home BP readings. In a relatively large, 3-month study, the authors demonstrated that patients with uncontrolled hypertension, randomized to using Medisafe, did not result in improved BP control compared with the control group. However, they did show a small, statistically significant, but clinically unimportant, improvement in medication adherence, measured by the 8-item Morisky Medication Adherence Scale. The study is a valuable addition to the growing body of literature assessing the role of mHealth technology in the health care sector; however, the results are disappointing for those of us who advocate for ongoing incorporation of mHealth strategies into current care.2